Media
Home
Media
- Press
Leriglitazone halts disease progression in adult patients with early cerebral adrenoleukodystrophy in compassionate-use study published in BrainIn a French early-access program study, 10 of 13 patients were clinically ...11/06/2024
Update on Regulatory Review of NEZGLYAL® (leriglitazone) in the EUDespite CHMP upholding the negative opinion for treatment of cerebral ...31/05/2024
Rare Disease Day 2024 - Call for greater awareness of X-linked adrenoleukodystrophy and cerebral adrenoleukodystrophy – special film launchedRare Disease Day 2024 - Call for greater awareness of X-linked ...29/02/2024Read more
- Events
Events in 2024
Events in 202322 Jun 2023 - 24 Jun 2023ULF Scientific Symposium and Family ConferenceCHICAGOEvents in 2022Events in 2021Events in 2020Events in 201911 Nov 2019 - 13 Nov 2019BIO-Europe 2019HAMBURG11 Nov 2019 - 13 Nov 2019World Orphan Drug CongressBARCELONA
Privacy Settings